Ed Zhang, MBA

Ed co-founded Overland Pharma as a venture partner at Hillhouse Capital in 2020 and has served as CEO since 2021.

Ed has a total of 20 years of biopharma industry experience. Before starting at Hillhouse, Ed was VP Corporate Development at Boston Pharmaceuticals as part of its initial founding team, leading corporate development and strategic initiatives. Prior to joining Boston Pharma, Ed headed global business development at Sanofi’s Specialty Products BU and was Director of Strategic Development at Genzyme before its acquisition by Sanofi. He started his career as a medicinal chemist at Pharmacia & Upjohn.

Ed holds B.S. from Nanjing University and M.B.A. from Kellogg School of Management at Northwestern University.